Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00902512Phase 4Completed
Phase 4, randomised, open-label trial of ASP-001 in erectile dysfunction (ED) (3 arms), sponsored by Viatris. Primary endpoints: Area Under the Curve from Time 0 to Last Quantifiable Concentration at 28 days and Maximum Plasma Concentration at 28 days. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00902512.